SCHEMBL4382673

SCHEMBL4382673

CCc1c(OCc2ccccc2)cc(OCc2ccccc2)c(-c2ccc(F)c(Cl)c2)c1CC1O[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)O1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.33
KDM1A O60341 4/20 0.33
PTGER1 P34995 2/20 0.32
MCL1 Q07820 1/20 0.32
MAPK14 Q16539 1/20 0.32
SLC5A2 P31639 1/20 0.32
HTR1A P08908 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HMGCR P04035 1/20 0.32
AR P10275 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388737 1.00 ERN1 (0.33) ERN1KDM1APTGER1MCL1MAPK14
SCHEMBL4380968 0.93 AR (0.36) ERN1KDM1APTGER1MCL1MAPK14
SCHEMBL4386470 0.93 AR (0.36) ERN1KDM1APTGER1MCL1MAPK14
SCHEMBL4381280 0.91 MCL1 (0.34) ERN1KDM1APTGER1MCL1HTR1A
SCHEMBL4387026 0.91 MCL1 (0.34) ERN1KDM1APTGER1MCL1HTR1A
SCHEMBL4381387 0.87 MAPK14 (0.35) PTGER1MCL1MAPK14SLC5A2
SCHEMBL4384038 0.87 MAPK14 (0.35) PTGER1MCL1MAPK14SLC5A2
SCHEMBL4385084 0.87 MAPK14 (0.35) PTGER1MCL1MAPK14SLC5A2
SCHEMBL6025486 0.87 C5AR1 (0.37) KDM1AMAPK14HTR1ASLC6A2SLC6A4
SCHEMBL4392462 0.87 C5AR1 (0.37) KDM1AMAPK14HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P ERN1 1073/4885KDM1A 2589/4885PTGER1 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.